Montréal, Canada - November 11, 2010 - Theratechnologies (TSX: TH) announced today that the U.S. Food and Drug Administration ("FDA") has approved EGRIFTATM (tesamorelin for injection) as the first ...
November 12, 2010 — The US Food and Drug Administration (FDA) has approved tesamorelin acetate injection (Egrifta; Theratechnologies, Inc, and marketed by EMD Serono) as the first and only treatment ...
MELBOURNE, Australia -- HIV-infected patients treated with a growth hormone releasing hormone analog achieved modest reductions in abdominal and liver fat, researchers said. The results were also ...
Hosted on MSN
Tesamorelin studies show targeted visceral fat loss
Controlled clinical trials have shown tesamorelin, a growth hormone–releasing hormone analog, can significantly cut visceral fat while sparing subcutaneous fat. The effect has been replicated in ...
Please provide your email address to receive an email when new articles are posted on . “We have phenomenally successfully direct-acting antiretrovirals for HIV that have saved the lives of people and ...
Tesamorelin is increasingly used as a laboratory tool when investigators need a GHRH analog reference material that can be applied consistently across receptor pharmacology assays, secretome profiling ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Review the side-effects of Tesamorelin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Discover comprehensive details about Tesamorelin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results